Publications: Women's health and cognition
- Incident major depressive disorder predicted by three measures of insulin resistance: a Dutch cohort study. Watson KT, Simard JF, Henderson VW, Nutkiewicz L, Lamers F, Nasca C, Rasgon N, Penninx BWJH. American Journal of Psychiatry, 2021 [Accepted for publication]
- Association of insulin resistance with depression severity and remission status: defining a metabolic endophenotype of depression. Watson KT, Simard JF, Henderson VW, Nutkiewicz L, Lamers F, Rasgon N, Penninx B. JAMA Psychiatry 78(4):439-441, 2020. PMID: 33263725; PMCID: PMC7711568. doi: 10.1001/jamapsychiatry.2020.3669
- PM2.5 associated with gray matter atrophy reflecting increased Alzheimer’s risk in older women. Younan D, Wang X, Casanova R, Barnard R, Gaussoin SA, Saldana S, Petkus AJ, Beavers DP, Resnick SM, Manson JE, Serre ML, Vizuete W, Henderson VW, Sachs BC, Salinas JA, Gatz M, Espeland MA, Chui HC, Shumaker SA, Rapp SR, Chen J-C. Neurology 2020. [Online ahead of print] doi: 10.1212/WNL.0000000000011149. PMID: 33208540
- PM2.5 associated with gray matter atrophy reflecting increased Alzheimer’s risk in older women. Younan D, Wang X, Casanova R, Barnard R, Gaussoin SA, Saldana S, Petkus AJ, Beavers DP, Resnick SM, Manson JE, Serre ML, Vizuete W, Henderson VW, Sachs BC, Salinas JA, Gatz M, Espeland MA, Chui HC, Shumaker SA, Rapp SR, Chen J-C. Neurology 2020. [Online ahead of print] doi: 10.1212/WNL.0000000000011149. PMID: 33208540
- Association of visual impairment with risk of incident dementia in a Women’s Health Initiative population. Tran EM, Stefanick ML, Henderson VW, Rapp SR, Chen JC, Armstrong NM, Espeland MA, Gower EW, Shadyab AH, Li W, Stone KL, Pershing S. JAMA Ophthalmology 138(6):624-633, 2020. PMID: 32297918; PMCID: PMC7163778. doi: 10.1001/jamaophthalmol.2020.0959
- Low-fat dietary pattern and global cognitive function: Exploratory analyses of the Women’s Health Initiative (WHI) randomized Dietary Modification trial. Chlebowski RT, Rapp S, Aragakic AK, Pan K, Neuhouserc ML, Snetselaard LG, Manson JE, Wactawski-Wendef J, Johnson KC, Hayden K, Baker LD, Henderson VW, Garciai L, Qi L, Prentice RL. EClinicalMedicine 18:100240, 2020. doi:10.1016/j.eclinm.2019.100240 [PMID: 31938786]
- Low-fat dietary pattern and global cognitive function: Exploratory analyses of the Women’s Health Initiative (WHI) randomized Dietary Modification trial. Chlebowski RT, Rapp S, Aragakic AK, Pan K, Neuhouserc ML, Snetselaard LG, Manson JE, Wactawski-Wendef J, Johnson KC, Hayden K, Baker LD, Henderson VW, Garciai L, Qi L, Prentice RL. EClinicalMedicine 18:100240, 2020. doi:10.1016/j.eclinm.2019.100240 [PMID: 31938786]
- Menopausal estrogen-alone therapy and health outcomes in women with and without bilateral oophorectomy. Manson JE, Aragaki AK, Bassuk SS, Chlebowski RT, Anderson GL, Rossouw JE, Howard BV, Thomson CA, Stefanick ML, Kaunitz AM, Crandall CJ, Eaton CB, Henderson VW, Liu S, Luo J, Rohan T, Shadyab AH, Wells G, Wactawski-Wende J, Prentice RL; WHI Investigators. Annals of Internal Medicine 71(6):406-414, 2019. doi:10.7326/M19-0274 [PMID: 31499528]
- Physical function and age at natural menopause: two take-home messages. Henderson VW. Menopause 26(9):943-944, 2019. doi:10.1097/GME.0000000000001401. PMID: 31453953
- Robust norms for neuropsychological tests of verbal episodic memory in Australian women. Goodwill AM, Campbell S, Henderson VW, Gorelik A, Dennerstein L, McClung M, Szoeke C. Neuropsychology 33(4)581-595, 2019. doi:10.1037/neu0000522 [PMID: 30829514]
- Differential effect of plasma estradiol on subclinical atherosclerosis progression in early vs late postmenopause. Sriprasert I, Hodis HN, Karim R, Stanczyk FZ, Shoupe D, Henderson VW, Mack WJ. Journal of Clinical Endocrinology and Metabolism 104(2):293-300, 2019. doi:10.1210/jc.2018-01600. [PMID: 30272234; PMCID: PMC6300071]
- Apolipoprotein e4 genotype in combination with poor metabolic profile is associated with cognitive deficit in healthy postmenopausal women: implications for late onset Alzheimer's disease. Karim R, Koc M, Rettberg JR, Hodis HN, Henderson VW, St. John JA, Allayee H, Brinton RD, Mack WJ. Menopause 26(1):7-15, 2019. PMID: 29975287; PMCID: PMC7508039. doi: 10.1097/GME.0000000000001160
- Progesterone and human cognition. Henderson VW. Climacteric 21(4):333-340, 2018. doi:10.1080/13697137.2018.1476484 [PMID: 29852783; PMCID: PMC6309195]
- Effect of reproductive history and exogenous hormone use on cognitive function in mid- and late life. Karim R, Dang H, Henderson VW, Hodis HN, St John J, Brinton RD, Mack WJ. J Am Geriatr Soc. 2016; 64(12):2448-56
- Predictive factors for verbal memory performance over decades of aging: data from the Women's Healthy Ageing Project. Szoeke C, Lehert P, Henderson VW, Dennerstein L, Desmond P, Campbell S. Am J Geriatr Psychiatry. 2016; 24(10):857-67
- Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis. Henderson VW, St John JA, Hodis HN, McCleary CA, Stanczyk FZ, Shoupe D, Kono N, Dustin L, Allayee H, Mack WJ. Neurology. 2016; 87(7):699-708
- Cognition and the menopause transition. Maki PM, Henderson VW. Menopause. 2016; 23(7):803-5
- Association of bilateral oophorectomy with cognitive function in healthy, postmenopausal women. Kurita K, Henderson VW, Gatz M, St John J, Hodis HN, Karim R, Mack WJ. Fertil Steril. 2016; 106(3):749-6
- Vascular effects of early versus late postmenopausal treatment with estradiol. Hodis HN, Mack WJ, Henderson VW, Shoupe D, Budoff MJ, Hwang-Levine J, Li Y, Feng M, Dustin L, Kono N, Stanczyk FZ, Selzer RH, Azen SP; ELITE Research Group. N Engl J Med. 2016; 374(13):1221-31
- Identifying postmenopausal women at risk for cognitive decline within a healthy cohort using a panel of clinical metabolic indicators: potential for detecting an at-Alzheimer's risk metabolic phenotype. Rettberg JR, Dang H, Hodis HN, Henderson VW, St John JA, Mack WJ, Brinton RD. Neurobiol Aging. 2016; 40:155-63
- 2016 IMS Recommendations on women's midlife health and menopause hormone therapy. Baber RJ, Panay N, Fenton A; IMS Writing Group. Climacteric. 2016; 19(2):109-50
- Raloxifene for women with Alzheimer disease: a randomized controlled pilot trial. Henderson VW, Ala T, Sainani KL, Bernstein AL, Stephenson BS, Rosen AC, Farlow MR. Neurology 2015; 85 (22):1937-44
- Prehypertension in midlife is associated with worse cognition a decade later in middle-age and older women. Chen KHM, Henderson VW, Stolwyk RJ, Dennerstein L, Szoeke C. Age and Ageing 2015; 44 (3):439-45
- Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis. Hodis HN, Mack WJ, Shoupe D, Azen SP, Stanczyk FZ, Hwang-Levine J, Budoff MJ, Henderson VW. Menopause 2015; 22 (4):391-401
- Sex modifies the APOE-related risk of developing Alzheimer’s disease. Altmann A, Tian L, Henderson VW, Greicius MD; ADNI Investigators. Annals of Neurology 2014; 75 (4):563-73
- Prevention of diseases after menopause. Lobo RA, Davis SR, De Villiers TJ, Gompel A, Henderson VW, Hodis HN, Lumsden MA, Mack WJ, Shapiro S, Baber RJ. Climacteric 2014; 17 (5):540-56
- The role of grandparenting in postmenopausal women’s cognitive health: results from the Women’s Healthy Ageing Project. Burn KF, Henderson VW, Ames D, Dennerstein L, Szoeke C. Menopause 2014; 21 (10):1069-74
- Dehydroepiandrosterone-sulfate (DHEAS) and cognition in midlife postmenopausal women. Chua CK, Henderson VW, Dennerstein L, Ames D, Szoeke C. Neurobiology of Aging 2014; 35 (7):1654-55
- Alzheimer’s disease: review of hormone therapy trials and implications for treatment and prevention after menopause. Henderson VW. Journal of Steroid Biochemistry and Molecular Biology 2014; 142:99-106
- Associations of urine excretion of isoflavonoids with cognition in postmenopausal women in the Women’s Isoflavone Soy Health clinical trial. St. John JA, Henderson VW, Hodis HN, Kono N, McCleary CA, Franke AA, Mack WJ. Journal of the American Geriatrics Society 2014; 62 (4):629-35
- Alzheimer’s disease. Reference Module in Biomedical Sciences. Henderson VW, Kerchner GA. NY: Elsevier, 2014; doi:10.1016/B978-0-12-801238-3.00017-9
- Is there a link between gynecological surgeries and Alzheimer disease? Rocca WA, Henderson VW. Neurology 2014; 82 (3):196-7
- Cognition, mood, and physiological concentrations of sex hormones in the early and late postmenopause. Henderson VW, St. John JA, Hodis HN, McCleary CA, Stanczyk FZ, Karim R, Shoupe D, Kono N, Dustin L, Allayee H, Mack WJ. Proceedings of the National Academy of Sciences of the United States of America 2013; 110 (50):20290-95
- Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. de Villiers TJ, Pines A, Panay N, Gambacciani M, Archer DF, Baber RJ, Davis SR, Gompel AA, Henderson VW, Langer R, Lobo RA, Plu-Bureau G, Sturdee DW; International Menopause Society. Climacteric 2013; 16 (3):316-37
- Exploring the interaction between SNP genotype and postmenopausal hormone therapy effects on stroke risk. Huang Y, Ballinger DG, Stokowski R, Beilharz E, Robinson JG, Liu S, Robinson R, Henderson VW, Rossouw JE, Prentice RL. Genome Medicine 2012; 4 (7):57
- Estrogen alpha-receptor (ESR1) variant is associated with two-year memory decline in midlife Australian women. Boussman CA, Szoeke C, Chen K, Dennerstein L, Henderson VW, Everall IP. Neuropsychobiology 2012; 66 (4):259-65
- Gender differences in verbal learning in older participants. Hogervorst E, Rahardjo TB, Jolles J, Brayne C, Henderson VW. Aging Health 2012; 8 (5):493-507
- Long-term soy isoflavone supplementation and cognition in women: A randomized, controlled trial. Henderson VW, St John JA, Hodis HN, Kono N, McCleary CA, Franke AA, Mack WJ. Neurology. 2012; 78 (23): 1841-1848
- Hormone levels and cognitive function in postmenopausal midlife women. Ryan J, Stanczyk FZ, Dennerstein L, Mack WJ, Clark MS, Szoeke C, Kildea D, Henderson VW. Neurobiol Aging. 2012; 33 (3): 617.e11-22
- Hormone therapy and the risk of stroke: perspectives 10 years after the Women's Health Initiative trials. Henderson VW, Lobo RA. Climacteric. 2012; 15 (3): 229-34
- Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on. Maki PM, Henderson VW. Climacteric. 2012; 15 (3): 256-62
- Effects of physical activity on vasomotor symptoms: examination using objective and subjective measures. Elavsky S, Gonzales JU, Proctor DN, Williams N, Henderson VW. Menopause. 2012
- Effects of endogenous and exogenous estrogen exposures in midlife and late-life women on episodic memory and executive functions. Henderson VW, Popat RA. Neuroscience. 2011: 191 129-38
- Executive functions in recently postmenopausal women: absence of strong association with serum gonadal steroids. Ryan J, Stanczyk FZ, Dennerstein L, Mack WJ, Clark MS, Szoeke C, Henderson VW. Brain Res. 2011: 1379 199-205
- Gonadal hormones and cognitive aging: a midlife perspective. Henderson VW, Womens Health (Lond Engl). 2011; 7 (1): 81-93
- Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in life. Maki PM, Dennerstein L, Clark M, Guthrie J, LaMontagne P, Fornelli D, Little D, Henderson VW, Resnick SM. Brain Res. 2011: 1379 232-43
- Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Sturdee DW, Pines A, Archer DF, Baber RJ, Barlow D, Birkhäuser MH, Brincat M, Cardozo L, de Villiers TJ, Gambacciani M, Gompel AA, Henderson VW, Kluft C, Lobo RA, MacLennan AH, Marsden J, Nappi RE, Panay N, Pickar JH, Robinson D, Simon J, Sitruk-Ware RL, Stevenson JC. Climacteric. 2011; 14 (3): 302-20
- Subtypes of mild cognitive impairment in older postmenopausal women: the Women's Health Initiative Memory Study. Rapp SR, Legault C, Henderson VW, Brunner RL, Masaki K, Jones B, Absher J, Thal L. Alzheimer Dis Assoc Disord. 2010 Jul-Sep; 24 (3): 248-55
- Action of estrogens in the aging brain: dementia and cognitive aging. Henderson VW, Biochim Biophys Acta. 2010; 1800 (10): 1077-83
- Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy. Henderson VW, Brinton RD. Prog Brain Res. 2010: 182 77-96
- Postmenopausal hormone therapy: an Endocrine Society scientific statement. Santen RJ, Allred DC, Ardoin SP, Archer DF, Boyd N, Braunstein GD, Burger HG, Colditz GA, Davis SR, Gambacciani M, Gower BA, Henderson VW, Jarjour WN, Karas RH, Kleerekoper M, Lobo RA, Manson JE, Marsden J, Martin KA, Martin L, Pinkerton JV, Rubinow DR, Teede H, Thiboutot DM, Utian WH. J Clin Endocrinol Metab. 2010; 95 (7 Suppl 1): s1-s66
- Summary of the National Institute on Aging-sponsored conference on depressive symptoms and cognitive complaints in the menopausal transition. Maki PM, Freeman EW, Greendale GA, Henderson VW, Newhouse PA, Schmidt PJ, Scott NF, Shively CA, Soares CN. Menopause. 2010; 17 (4): 815-22
- The relationship between cognitive function and physical performance in older women: results from the women's health initiative memory study. Atkinson HH, Rapp SR, Williamson JD, Lovato J, Absher JR, Gass M, Henderson VW, Johnson KC, Kostis JB, Sink KM, Mouton CP, Ockene JK, Stefanick ML, Lane DS, Espeland MA. J Gerontol A Biol Sci Med Sci. 2010; 65 (3): 300-6
- A prospective study of the association between endogenous hormones and depressive symptoms in postmenopausal women. Ryan J, Burger HG, Szoeke C, Lehert P, Ancelin ML, Henderson VW, Dennerstein L. Menopause. 2009 May-Jun; 16 (3): 509-17
- Aging, estrogens, and episodic memory in women. Henderson VW, Cogn Behav Neurol. 2009; 22 (4): 205-14
- Frontiers proposal. National Institute on Aging "bench to bedside: estrogen as a case study". Asthana S, Brinton RD, Henderson VW, McEwen BS, Morrison JH, Schmidt PJ. Age (Dordr). 2009; 31 (3): 199-210
- Menopause, cognitive ageing and dementia: practice implications. Henderson VW, Menopause Int. 2009; 15 (1): 41-4
- Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. Utian WH, Archer DF, Bachmann GA, Gallagher C, Grodstein F, Heiman JR, Henderson VW, Hodis HN, Karas RH, Lobo RA, Manson JE, Reid RL, Schmidt PJ, Stuenkel CA. Menopause. 2008 Jul-Aug; 15 (4 Pt 1): 584-602
- Surgical versus natural menopause: cognitive issues. Henderson VW, Sherwin BB. Menopause. 2007 May-Jun; 14 (3 Pt 2): 572-9
- Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study. MacLennan AH, Henderson VW, Paine BJ, Mathias J, Ramsay EN, Ryan P, Stocks NP, Taylor AW. Menopause. 2006 Jan-Feb; 13 (1): 28-36
- Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research. Henderson VW, Neuroscience. 2006; 138 (3): 1031-9
- Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. Yaffe K, Krueger K, Cummings SR, Blackwell T, Henderson VW, Sarkar S, Ensrud K, Grady D. Am J Psychiatry. 2005; 162 (4): 683-90
- Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. Henderson VW, Benke KS, Green RC, Cupples LA, Farrer LA. J Neurol Neurosurg Psychiatry. 2005; 76 (1): 103-5
- Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D. JAMA. 2003; 289 (20): 2663-72
- Estrogen exposures and memory at midlife: a population-based study of women. Henderson VW, Guthrie JR, Dudley EC, Burger HG, Dennerstein L. Neurology. 2003; 60 (8): 1369-71
- Serum lipids and memory in a population based cohort of middle age women. Henderson VW, Guthrie JR, Dennerstein L. J Neurol Neurosurg Psychiatry. 2003; 74 (11): 1530-5
- Hormone therapy and risk of Alzheimer disease: a critical time. Resnick SM, Henderson VW. JAMA. 2002; 288 (17): 2170-2
- Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Henderson VW, Paganini-Hill A, Miller BL, Elble RJ, Reyes PF, Shoupe D, McCleary CA, Klein RA, Hake AM, Farlow MR. Neurology. 2000; 54 (2): 295-301